US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist

149.960
+6.010+4.18%

Close May 1 16:00 ET

150.010
+0.050+0.03%

Post 18:45 ET

18.96BMarket Cap-42602P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

119.24%104.16M

77.42%-29.8M

411.76%359.41M

51.97%-58.99M

2.76%-166.48M

15.65%-541.27M

12.10%-131.98M

13.99%-115.28M

-0.79%-122.82M

27.36%-171.19M

Net income from continuing operations

61.08%-440.24M

33.55%-137.87M

136.40%147.75M

0.50%-276.02M

27.56%-174.1M

-32.64%-1.13B

19.72%-207.49M

-98.48%-405.92M

-46.34%-277.4M

-20.00%-240.34M

Operating gains losses

-47.23%107.94M

30.71%22.34M

-56.12%48.05M

-12.70%28.82M

-80.56%8.74M

1,285.01%204.56M

-29.85%17.09M

11,272.79%109.52M

644.41%33.01M

195.59%44.94M

Depreciation and amortization

13.42%97.03M

-3.66%23.97M

13.96%23.53M

15.86%23.45M

31.86%26.08M

-4.62%85.55M

16.01%24.89M

-11.07%20.65M

-37.58%20.24M

56.96%19.78M

Other non cash items

2.20%106.99M

191.64%12.98M

82.75%50.61M

-34.83%24.4M

-45.87%19M

-22.92%104.68M

-86.53%4.45M

106.78%27.69M

85.79%37.44M

-49.30%35.1M

Change In working capital

130.26%10.76M

149.67%6.79M

448.47%25.53M

93.17%64.58M

-43.65%-86.14M

78.16%-35.55M

9.50%-13.68M

1,100.86%4.65M

256.36%33.43M

52.36%-59.96M

-Change in receivables

-92.86%-87.94M

107.26%3.87M

-181.06%-107.99M

-146.41%-2.97M

-51.75%19.15M

55.21%-45.6M

10.40%-53.27M

-1,146.95%-38.42M

118.12%6.4M

470.68%39.7M

-Change in inventory

153.81%18.37M

163.18%11.99M

160.82%4.8M

121.58%1.99M

-120.92%-403K

-29.23%-34.14M

-76.38%-18.98M

42.17%-7.88M

-132.62%-9.2M

-0.41%1.93M

-Change in prepaid assets

76.55%-9.03M

169.34%23.4M

-183.68%-3.32M

-30.82%-27.87M

95.86%-1.24M

-19.99%-38.51M

-47.89%8.69M

121.85%3.97M

-25.58%-21.31M

-118.63%-29.85M

-Change in payables and accrued expense

-57.85%80.84M

-137.68%-38.67M

70.25%118.74M

21.42%82.74M

-68.20%-81.98M

117.33%191.77M

159.78%102.62M

50.43%69.75M

-1.17%68.14M

26.79%-48.74M

-Change in other current liabilities

-7.72%-46.5M

-0.31%-11.49M

-8.59%-11.17M

-2.40%-11.02M

-20.19%-12.83M

-6.99%-43.17M

-6.38%-11.45M

0.82%-10.28M

-5.96%-10.76M

-17.79%-10.67M

-Change in other working capital

183.48%55.02M

142.85%17.69M

296.29%24.47M

13,644.30%21.72M

28.19%-8.85M

-30.77%-65.91M

-526.00%-41.28M

-49.25%-12.47M

100.66%158K

55.67%-12.33M

Cash from discontinued investing activities

Operating cash flow

119.24%104.16M

77.42%-29.8M

411.76%359.41M

51.97%-58.99M

2.76%-166.48M

15.65%-541.27M

12.10%-131.98M

13.99%-115.28M

-0.79%-122.82M

27.36%-171.19M

Investing cash flow

Cash flow from continuing investing activities

-298.61%-336.35M

-72.01%-240.66M

-103.43%-10.76M

-106.10%-8.71M

48.30%-76.22M

161.97%169.35M

66.16%-139.91M

455.60%313.89M

-9.06%142.79M

-306.61%-147.42M

Net PPE purchase and sale

13.67%-62.21M

29.24%-15.31M

-3.53%-17.09M

0.85%-15.92M

22.22%-13.89M

5.65%-72.06M

1.15%-21.64M

36.65%-16.51M

-42.76%-16.06M

-3.96%-17.86M

Net investment purchase and sale

-205.93%-269.7M

-89.91%-225.35M

-96.79%10.77M

-95.69%7.21M

51.87%-62.33M

232.22%254.61M

69.69%-118.66M

639.15%335.4M

-0.65%167.35M

-239.64%-129.49M

Net other investing changes

66.36%-4.44M

--0

----

-202.34%-13.19M

38,200.00%381K

---5M

-5,051.52%-8.5M

98.21%-75K

Cash from discontinued investing activities

Investing cash flow

-298.61%-336.35M

-72.01%-240.66M

-103.43%-10.76M

-106.10%-8.71M

48.30%-76.22M

161.97%169.35M

66.16%-139.91M

455.60%313.89M

-9.06%142.79M

-306.61%-147.42M

Financing cash flow

Cash flow from continuing financing activities

-59.57%172.13M

-38.16%39.23M

-88.84%33.14M

76.00%53.39M

32.66%46.37M

-65.86%425.75M

-78.30%63.44M

-48.24%297.02M

-90.80%30.34M

-31.70%34.96M

Net issuance payments of debt

--0

----

-49.20%254M

-52.87%117.83M

----

Proceeds from stock option exercised by employees

-43.14%147.46M

-45.53%30.89M

-83.79%24.81M

119.50%49.39M

56.22%42.37M

5.32%259.36M

25.92%56.71M

111.39%153.02M

-72.51%22.5M

-42.26%27.12M

Net other financing activities

128.16%24.67M

107.50%8.33M

6.38%8.33M

-48.94%4M

-48.93%4M

-117.49%-87.61M

-3,940.40%-111.11M

-98.44%7.83M

482.15%7.83M

86.50%7.83M

Cash from discontinued financing activities

Financing cash flow

-59.57%172.13M

-38.16%39.23M

-88.84%33.14M

76.00%53.39M

32.66%46.37M

-65.86%425.75M

-78.30%63.44M

-48.24%297.02M

-90.80%30.34M

-31.70%34.96M

Net cash flow

Beginning cash position

5.64%868.56M

-3.74%1.04B

14.24%659.98M

25.76%674.41M

5.64%868.56M

64.74%822.15M

-1.92%1.08B

-22.77%577.74M

40.38%536.26M

64.74%822.15M

Current changes in cash

-211.57%-60.06M

-10.92%-231.22M

-22.97%381.79M

-128.43%-14.31M

30.79%-196.32M

-83.79%53.83M

23.15%-208.45M

40.99%495.63M

-86.22%50.31M

-150.73%-283.66M

Effect of exchange rate changes

186.02%6.39M

573.07%10.9M

-423.72%-6.55M

98.53%-130K

197.23%2.18M

17.61%-7.43M

153.08%1.62M

164.48%2.02M

-917.30%-8.84M

42.76%-2.24M

End cash Position

-6.18%814.88M

-3.74%1.04B

14.24%659.98M

25.76%674.41M

5.64%868.56M

-1.92%1.08B

-22.77%577.74M

40.38%536.26M

Free cash flow

106.84%41.95M

70.64%-45.1M

359.74%342.32M

46.06%-74.91M

4.59%-180.37M

14.59%-613.33M

10.70%-153.61M

17.68%-131.79M

-4.34%-138.87M

25.23%-189.05M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	119.24%104.16M	77.42%-29.8M	411.76%359.41M	51.97%-58.99M	2.76%-166.48M	15.65%-541.27M	12.10%-131.98M	13.99%-115.28M	-0.79%-122.82M	27.36%-171.19M
Net income from continuing operations	61.08%-440.24M	33.55%-137.87M	136.40%147.75M	0.50%-276.02M	27.56%-174.1M	-32.64%-1.13B	19.72%-207.49M	-98.48%-405.92M	-46.34%-277.4M	-20.00%-240.34M
Operating gains losses	-47.23%107.94M	30.71%22.34M	-56.12%48.05M	-12.70%28.82M	-80.56%8.74M	1,285.01%204.56M	-29.85%17.09M	11,272.79%109.52M	644.41%33.01M	195.59%44.94M
Depreciation and amortization	13.42%97.03M	-3.66%23.97M	13.96%23.53M	15.86%23.45M	31.86%26.08M	-4.62%85.55M	16.01%24.89M	-11.07%20.65M	-37.58%20.24M	56.96%19.78M
Other non cash items	2.20%106.99M	191.64%12.98M	82.75%50.61M	-34.83%24.4M	-45.87%19M	-22.92%104.68M	-86.53%4.45M	106.78%27.69M	85.79%37.44M	-49.30%35.1M
Change In working capital	130.26%10.76M	149.67%6.79M	448.47%25.53M	93.17%64.58M	-43.65%-86.14M	78.16%-35.55M	9.50%-13.68M	1,100.86%4.65M	256.36%33.43M	52.36%-59.96M
-Change in receivables	-92.86%-87.94M	107.26%3.87M	-181.06%-107.99M	-146.41%-2.97M	-51.75%19.15M	55.21%-45.6M	10.40%-53.27M	-1,146.95%-38.42M	118.12%6.4M	470.68%39.7M
-Change in inventory	153.81%18.37M	163.18%11.99M	160.82%4.8M	121.58%1.99M	-120.92%-403K	-29.23%-34.14M	-76.38%-18.98M	42.17%-7.88M	-132.62%-9.2M	-0.41%1.93M
-Change in prepaid assets	76.55%-9.03M	169.34%23.4M	-183.68%-3.32M	-30.82%-27.87M	95.86%-1.24M	-19.99%-38.51M	-47.89%8.69M	121.85%3.97M	-25.58%-21.31M	-118.63%-29.85M
-Change in payables and accrued expense	-57.85%80.84M	-137.68%-38.67M	70.25%118.74M	21.42%82.74M	-68.20%-81.98M	117.33%191.77M	159.78%102.62M	50.43%69.75M	-1.17%68.14M	26.79%-48.74M
-Change in other current liabilities	-7.72%-46.5M	-0.31%-11.49M	-8.59%-11.17M	-2.40%-11.02M	-20.19%-12.83M	-6.99%-43.17M	-6.38%-11.45M	0.82%-10.28M	-5.96%-10.76M	-17.79%-10.67M
-Change in other working capital	183.48%55.02M	142.85%17.69M	296.29%24.47M	13,644.30%21.72M	28.19%-8.85M	-30.77%-65.91M	-526.00%-41.28M	-49.25%-12.47M	100.66%158K	55.67%-12.33M
Cash from discontinued investing activities
Operating cash flow	119.24%104.16M	77.42%-29.8M	411.76%359.41M	51.97%-58.99M	2.76%-166.48M	15.65%-541.27M	12.10%-131.98M	13.99%-115.28M	-0.79%-122.82M	27.36%-171.19M
Investing cash flow
Cash flow from continuing investing activities	-298.61%-336.35M	-72.01%-240.66M	-103.43%-10.76M	-106.10%-8.71M	48.30%-76.22M	161.97%169.35M	66.16%-139.91M	455.60%313.89M	-9.06%142.79M	-306.61%-147.42M
Net PPE purchase and sale	13.67%-62.21M	29.24%-15.31M	-3.53%-17.09M	0.85%-15.92M	22.22%-13.89M	5.65%-72.06M	1.15%-21.64M	36.65%-16.51M	-42.76%-16.06M	-3.96%-17.86M
Net investment purchase and sale	-205.93%-269.7M	-89.91%-225.35M	-96.79%10.77M	-95.69%7.21M	51.87%-62.33M	232.22%254.61M	69.69%-118.66M	639.15%335.4M	-0.65%167.35M	-239.64%-129.49M
Net other investing changes	66.36%-4.44M	--0	----	----	----	-202.34%-13.19M	38,200.00%381K	---5M	-5,051.52%-8.5M	98.21%-75K
Cash from discontinued investing activities
Investing cash flow	-298.61%-336.35M	-72.01%-240.66M	-103.43%-10.76M	-106.10%-8.71M	48.30%-76.22M	161.97%169.35M	66.16%-139.91M	455.60%313.89M	-9.06%142.79M	-306.61%-147.42M
Financing cash flow
Cash flow from continuing financing activities	-59.57%172.13M	-38.16%39.23M	-88.84%33.14M	76.00%53.39M	32.66%46.37M	-65.86%425.75M	-78.30%63.44M	-48.24%297.02M	-90.80%30.34M	-31.70%34.96M
Net issuance payments of debt	--0	--0	----	----	----	-49.20%254M	-52.87%117.83M	----	----	----
Proceeds from stock option exercised by employees	-43.14%147.46M	-45.53%30.89M	-83.79%24.81M	119.50%49.39M	56.22%42.37M	5.32%259.36M	25.92%56.71M	111.39%153.02M	-72.51%22.5M	-42.26%27.12M
Net other financing activities	128.16%24.67M	107.50%8.33M	6.38%8.33M	-48.94%4M	-48.93%4M	-117.49%-87.61M	-3,940.40%-111.11M	-98.44%7.83M	482.15%7.83M	86.50%7.83M
Cash from discontinued financing activities
Financing cash flow	-59.57%172.13M	-38.16%39.23M	-88.84%33.14M	76.00%53.39M	32.66%46.37M	-65.86%425.75M	-78.30%63.44M	-48.24%297.02M	-90.80%30.34M	-31.70%34.96M
Net cash flow
Beginning cash position	5.64%868.56M	-3.74%1.04B	14.24%659.98M	25.76%674.41M	5.64%868.56M	64.74%822.15M	-1.92%1.08B	-22.77%577.74M	40.38%536.26M	64.74%822.15M
Current changes in cash	-211.57%-60.06M	-10.92%-231.22M	-22.97%381.79M	-128.43%-14.31M	30.79%-196.32M	-83.79%53.83M	23.15%-208.45M	40.99%495.63M	-86.22%50.31M	-150.73%-283.66M
Effect of exchange rate changes	186.02%6.39M	573.07%10.9M	-423.72%-6.55M	98.53%-130K	197.23%2.18M	17.61%-7.43M	153.08%1.62M	164.48%2.02M	-917.30%-8.84M	42.76%-2.24M
End cash Position	-6.18%814.88M	-6.18%814.88M	-3.74%1.04B	14.24%659.98M	25.76%674.41M	5.64%868.56M	5.64%868.56M	-1.92%1.08B	-22.77%577.74M	40.38%536.26M
Free cash flow	106.84%41.95M	70.64%-45.1M	359.74%342.32M	46.06%-74.91M	4.59%-180.37M	14.59%-613.33M	10.70%-153.61M	17.68%-131.79M	-4.34%-138.87M	25.23%-189.05M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall